Is Telix Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Telix Pharmaceuticals Ltd (TLX.AX) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Telix Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Telix Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Telix Pharmaceuticals Ltd?

Muslim investors may consider investing in Telix Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Telix Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Telix Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Telix Pharmaceuticals Ltd updated?

The Shariah compliance status of Telix Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Telix Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Telix Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Telix Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

TLX.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 25, 2026

Report Source: 2025 Annual Report

Telix Pharmaceuticals Ltd. Stock Analysis TLX.AX

Australia Health Care Mid Cap Report: 2025 Annual

Telix Pharmaceuticals Limited.engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria and currently employs 1,120 full-time employees. The company went IPO on 2017-11-15. The company is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.

Key Statistics of Telix Pharmaceuticals Ltd (TLX.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD14.60AUD14.97

Today's Open

AUD14.95

Volume

1.12M

P/E Ratio (TTM)

52 Week Range

AUD8.26AUD27.40

Market Cap

5.29B

Avg. Volume

480.90K

Dividend Yield

Financial Metrics & Statements of Telix Pharmaceuticals Ltd (TLX.AX)

FAQ's for Telix Pharmaceuticals Ltd (TLX.AX)

According to Musaffa’s Shariah screening methodology, Telix Pharmaceuticals Ltd (TLX.AX) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.